Offering rapid access to world-class comprehensive cancer treatment at Cabrini Malvern

Cabrini External site image bw background

  • Cabrini and GenesisCare have announced a partnership to deliver a new, state-of-art radiotherapy service to offer both in-patients and out-patients comprehensive cancer care in the one location
  • In-patients will no longer need to travel off-site to receive daily radiotherapy treatment
  • The service will provide the local community with greater access to cutting edge clinical trials

Oncology patients will soon have access to fully integrated, comprehensive cancer care at Cabrini Hospital in Malvern, with the addition of radiotherapy to the hospital’s existing suite of diagnostic, surgical and medical cancer care. The new, state-of-the-art radiotherapy service will deliver world-class treatment to both in-patients and out-patients when it opens in September.

Providing radiotherapy on site at the Malvern campus will mean that in-patients will no longer need to travel by medical transport or ambulance to receive daily treatments. The service will be linked across Cabrini’s Malvern, Brighton and Prahran campuses, improving access to radiotherapy services for all patients within the region.

Radiotherapy is a highly effective weapon in the fight against cancer, delivering more than 40 per cent of all cures. Using a highly sophisticated machine called a linear accelerator, GenesisCare will be providing non-invasive radiotherapy that precisely delivers radiation beams to eradicate cancer cells.

In an Australian-first, the innovative $7 million facility – being developed and operated by Australia’s largest radiotherapy service provider, GenesisCare – will use unique prefabricated building blocks to develop the contemporary radiotherapy bunker. The build will take less than four months.

GenesisCare Managing Director, Dan Collins, said the organisation was committed to innovating healthcare to make it easier for patients with cancer to access quality care.

“We’re incredibly pleased to be partnering alongside Cabrini to enable rapid access for cancer patients to state-of-the-art radiotherapy treatments and technologies. For patients in the community undergoing cancer treatment, our new on site services will make it simpler and easier to access the best care at the right time,” he said.

Highly experienced Radiation Oncologists, Dr Karen Taylor, Dr Ian Porter, Dr David Blakey and Dr Mario Guerrieri will be bringing their expertise to the campus to deliver patient-centred care.

“Cabrini is delighted with the Radiation Oncology medical team GenesisCare has assembled. They are all clinicians with strong, established clinical reputations, who will bring a diverse and comprehensive range of expertise to provide care to our cancer patients,” said Dr Simon Woods,
Executive Director, Cabrini Malvern.

The new service will create approximately 15 new jobs for specialist clinical and support staff, and it is anticipated that more than 7000 treatments will be provided at the facility during its first year of operation.

Building our resilience to support patients

news ada

A cancer diagnosis can take a psychological toll on the individual and their family, with a rollercoaster of emotions along the way. Our patients have told us that their daily interactions with our team – whether it’s a welcoming smile on arrival or a chat over a coffee – can have a positive impact on what can be a sometimes testing journey.

To better support our teams to better support our patients, GenesisCare has partnered with clinical psychologist Dr Cath Adams to run a series of workshops focused on building resilience, eliciting and responding to emotional cues, and managing challenging conversations.

Our CancerCare Patient Experience Lead, Ada Ryan, said: “We monitor patient sentiment every month, and I’m always blown away by how much positive feedback there is for our teams. They have the most profound impact on the patient experience, so we are focused on looking for ways to better support them.”

The workshops were trialled in New South Wales and have been deemed an overwhelmingly success by participants. They will now be rolled out nationally.

GenesisCare recognises that the more positive and engaged our team are, the better the patient experience is. These types of initiatives help us continuously empower our team to deliver high quality care to patients.

Improving patient outcomes through research

ICTD Story

GenesisCare is championing research and celebrating its passionate clinical teams and patients involved in trials this International Clinical Trials Day.

Commemorated on or near 20 May, International Clinical Trials Day marks the day James Lind began what is believed to be the world's first controlled clinical trial against the deadly disease scurvy. In 1747, he developed the theory that citrus fruits cured scurvy and the results of his trial saved the lives of thousands of sailors.

Fast forward to 2017, life expectancy has improved dramatically, attributable to advances in science, medical research and public health policies.i

GenesisCare Chief Medical Officer Dr Nathaniel Heiner said research underpinned our ability to deliver world-class treatment to our patients.

Read more ...

Dr Phuong Tran Awarded SA Camp Quality Volunteer of the Year Award

tran 2

Recently, Dr Phuong Tran, a Radiation Oncologist, with Adelaide Radiotherapy Centre, was awarded the 2016 Camp Quality Volunteer of the Year Award in SA. Camp Quality is a charity that supports young children living with cancer and their families. Members from Camp Quality, ARC Radiation Oncologists and members of the Executive Team, were on hand to see Dr Tran receive her well-deserved award, from General Manager of Camp Quality SA/NT, Heather Keele.

Dr Tran has been a Medical Volunteer with Camp Quality for 10 years and has attended over 20 camps and fun days over this time. In addition to caring for the children while on camps, she has educated volunteers about keeping the children safe and healthy during Volunteer Training Days, and provides medical advice to the organisation as required.

Read more ...

New treatment mix to improve outcomes for elderly brain tumour patients

Brain image

An international trial published in the New England Journal of Medicine has demonstrated that a new treatment mix can prolong survival for elderly patients with the most common type of brain tumour called glioblastoma.

A short course of radiotherapy, in conjunction with an oral chemotherapy drug called temozolomide, resulted in longer survival than radiotherapy alone for patients with glioblastoma aged over 64 years.

GenesisCare Newcastle Radiation Oncologist, and the study's co-principal investigator in Australia, Dr Mike Fay said the trial, which was one of the largest ever into glioblastoma, was much needed.

Read more ...

Genesis Logo Small.pngGenesisCare is Australia’s leading provider of radiation oncology, cardiology and sleep treatments. We exist to fill the treatment gap for the biggest disease burdens in Australia - cancer and heart care - in an environment of substantial unmet demand from an ageing population. Click here to learn more